Atria Wealth Solutions, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Atria Wealth Solutions, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$0.16 - $0.74 $1,600 - $7,400	10,000 New	10,000 $1,000
Q4 2022 Aug 30, 2023	BUY	$0.46 - $1.21 $4,600 - $12,100	10,000 New	10,000 $5,000
Q4 2022 Feb 13, 2023	SELL	$0.46 - $1.21 $4,600 - $12,100	-10,000 Reduced 50.0%	10,000 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $9,800 - $24,000	20,000 New	20,000 $13,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.